Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High Dose Ascorbic Acid (HDAA) in Patients With Plasma Cell Disorders

NCT06313502 is registered in ClinicalTrials.gov with University of Arkansas as lead sponsor.

NCT NCT06313502
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06313502 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High Dose Ascorbic Acid (HDAA) in Patients With Plasma Cell Disorders
Lead sponsor
University of Arkansas
Phase
Phase 1
Overall status
Recruiting
Start date
July 19, 2024
Completion date
April 30, 2028
Enrollment
18 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

plasma cell disorder